IGFBP2 and epilepsy: CNVs within the 15q11.2 genomic loci (BP1-BP2) have been shown to confer risk to epilepsy and developmental delay [39], [40], while deletions of the 15q13 region (BP4-BP5) were associated with increased risk for intellectual disability and epilepsy [41].